Flyover Capital — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesKansas City, US
Kyle McAllister(CEO & Founder)inTrevor Welch(Executive Officer, Director)in
Board seatThad Langford· per SEC Form D
Co-investorsAlpaca VCCorigin VenturesGaingelsRedbud VCThe CouncilAtria Ventures+2 more
Mavvrik provides a platform for real-time financial control and cost management across cloud, on-premise, and AI spending.
AI & Machine LearningCloud ComputingEnterprise SoftwareSaaSAustin, US
Darmawan Suwirya(Founder)inPaul Franz(Founder)in
Co-investorsAmplify.LAKnoll VenturesS3 VenturesTech Square VenturesTuesday Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




__Twitter.png)







